Due to the COVID-19 pandemic, the ACP office is closed to the public as our staff work remotely. Click here to see how this impacts our programs and operations.

Shortage of drug used to treat depression

December 9, 2020

Availability of phenelzine sulfate tablets expected to be intermittent and future supply cannot be guaranteed by Health Canada.

There is currently a shortage of phenelzine sulfate Tablets USP (NARDIL), 15 mg (DIN 00476552) in Canada due to a global shortage of an active ingredient. Phenelzine sulfate is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of certain types of depression. The resupply date is unknown at this point.

Phenelzine is currently listed on the Tier 3 list of shortages. Tier 3 shortages are those with the greatest impact on supply and drugs on this list are in high demand or currently in shortage.

For more on the shortage, including who is affected and how to report health or safety concerns, please visit the Health Canada website.

← Previous ArticleNext Article →